Acción TNGX TANGO THERAPEUTICS, INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Tango Therapeutics, Inc.

Acciones

TNGX

US87583X1090

Mercado cerrado - Nasdaq
Otros sitios de cotización
 22:00:00 21/06/2024 		Varia. Cinco días. Varia. 1 de enero.
10,1 USD +5,76 % Gráfico intradía de Tango Therapeutics, Inc. +13,10 % +2,02 %
11/06 Transcript : Tango Therapeutics, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 02:40 PM
28/05 TANGO THERAPEUTICS, INC. : Obtiene una recomendación de compra de HC Wainwright ZM

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!
Inscripción 100% Gratuita
Tango Therapeutics : Corporate Presentation
Tango Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
Tango Therapeutics Stops Development of USP1 Inhibitor After Liver Toxicity Issues
Sector Update: Health Care Stocks Flat to Lower Premarket Thursday
Sector Update: Health Care
Tango Therapeutics Discontinues TNG348 Program After Showing Liver Toxicity in Trials; Shares Tumble Premarket
Medivir´s licensee, Tango Therapeutics, has discontinued development of its TNG348 clinical program
Medivir's licensee, Tango Therapeutics, has discontinued development of its TNG348 clinical program
Tango Therapeutics to stop development of cancer therapy
Tango Therapeutics : Corporate Presentation
Tango Therapeutics Announces Discontinuation of TNG348 Program
Tango Therapeutics Announces Discontinuation of TNG348 Program
Tango Appoints Tim Redfern as Chief Financial Officer
Tango Therapeutics : Corporate Presentation
Tango Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Tango Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights
British billionaire Joe Lewis fined $5 million by US judge for insider trading
Multibillionaire Joe Lewis to face US sentencing for insider trading
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Earnings Flash (TNGX) TANGO THERAPEUTICS Reports Q4 Revenue $5.4M
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción TNGX
  4. Noticias Tango Therapeutics, Inc.
  5. Otros idiomas